Aclaris Therapeutics to Participate in Two September Healthcare Conferences
Core Insights - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases [3] Group 1: Upcoming Events - Aclaris will participate in two healthcare conferences in September 2025 [1] - The first event is a fireside chat at the Cantor Global Healthcare Conference on September 3, 2025, at 1:00 PM EDT [4] - The second event is a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, at 9:00 AM EDT [4] Group 2: Webcast Information - Live and archived webcasts of both events will be accessible on Aclaris' website for at least 30 days [2]
